Literature DB >> 17686527

Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy.

Jing-Xian Zhao1, Yao-Ying Zeng, Yi Liu.   

Abstract

Increasing evidence suggests that CD4(+)CD25(+) regulatory T cells (Tregs) participate in the development of maternal tolerance to the fetus during pregnancy; however, the factors controlling the activities of Tregs are poorly understood. In the present study, CD4(+)CD25(+) Tregs were analyzed in syngeneically pregnant mice (BALB/cxBALB/c), allogeneically pregnant mice (BALB/cxC57), ovariectomized mice and pregnant women to investigate the influences of fetal alloantigens and pregnancy-related hormones on the activities of Tregs. It was demonstrated that the frequencies of CD4(+)CD25(+) Tregs increase more in allogeneically than in syngeneically pregnant mice, which contributes to a lowered alloreactivity against paternal antigens in allogeneically compared with syngeneically pregnant mice. The increased Tregs are most likely to be induced in peripheral lymphoid tissues, rather than develop in thymus. Allogeneically mated mice and humans share similar dynamic changes in Treg frequencies, markedly increasing during early pregnancy and progressively decreasing from mid-gestation onwards to return to non-pregnant levels at term. Induction of labor in humans appears to be associated with a decrease of CD4(+)CD25(high) Tregs and increase of CD4(+)CD25(low) T cells. Neither estrogen or progesterone alone, nor their combination, shows an impact on the frequencies of Tregs in ovariectomized mice. These results suggest that fetal alloantigen is responsible for the increase of Tregs during pregnancy, and the expansion of the Treg population is of importance for the allogeneic fetus to evade immune attack from the mother.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686527     DOI: 10.1016/j.jri.2007.06.052

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  50 in total

1.  FTY720 mediates activation suppression and G(0)/G (1) cell cycle arrest in a concanavalin A-induced mouse lymphocyte pan-activation model.

Authors:  Xiangfeng Zeng; Tong Wang; Cairong Zhu; Yanxia Ye; Bing Song; Xinqiang Lai; Yaoying Zeng
Journal:  Inflamm Res       Date:  2012-03-10       Impact factor: 4.575

2.  Maternal CD4⁺ and CD8⁺ T cell tolerance towards a fetal minor histocompatibility antigen in T cell receptor transgenic mice.

Authors:  Antoine L Perchellet; Susmita Jasti; Margaret G Petroff
Journal:  Biol Reprod       Date:  2013-10-31       Impact factor: 4.285

3.  Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice.

Authors:  Sarah A Robertson; Leigh R Guerin; John J Bromfield; Kim M Branson; Aisling C Ahlström; Alison S Care
Journal:  Biol Reprod       Date:  2009-01-21       Impact factor: 4.285

4.  Origin of Foxp3(+) cells during pregnancy.

Authors:  Ana Teles; Catharina Thuere; Paul Ojiambo Wafula; Tarek El-Mousleh; Maria Laura Zenclussen; Ana Claudia Zenclussen
Journal:  Am J Clin Exp Immunol       Date:  2013-10-16

5.  Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells.

Authors:  Rosanna Ramhorst; Laura Fraccaroli; Paulomi Aldo; Ayesha B Alvero; Ingrid Cardenas; Claudia Perez Leirós; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2011-08-07       Impact factor: 3.886

Review 6.  T cell behavior at the maternal-fetal interface.

Authors:  Patrice Nancy; Adrian Erlebacher
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

Review 7.  Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease.

Authors:  Trevor D Burt
Journal:  Am J Reprod Immunol       Date:  2013-02-25       Impact factor: 3.886

Review 8.  Regulatory T cells in embryo implantation and the immune response to pregnancy.

Authors:  Sarah A Robertson; Alison S Care; Lachlan M Moldenhauer
Journal:  J Clin Invest       Date:  2018-10-01       Impact factor: 14.808

Review 9.  Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.

Authors:  Shernan G Holtan; Douglas J Creedon; Paul Haluska; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

Review 10.  Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?

Authors:  Leigh R Guerin; Jelmer R Prins; Sarah A Robertson
Journal:  Hum Reprod Update       Date:  2009-03-11       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.